Emails show Olympus hiked duodenoscope prices post deadly CRE outbreak, GI Dynamics names Scott Schorer CEO — 8 GI company key notes

Here are eight recent news updates on key gastroenterology and endoscopy companies.

Olympus is once again embroiled in controversy following the discovery of emails that show the company pushed up the price of duodenoscopes after the deadly Carbapenem-resistant Enterobacteria outbreak at UCLA's Ronald Reagan Medical Center, which left three dead.

Olympus unveiled the VISERA 4K UHD System.

Cairn Diagnostics launched the 13C-Spirulina Gastric Emptying Breath Test.

Zacks Investment Research upgraded EndoChoice Holdings from a "hold" rating to a "buy" rating.

Zydus Healthcare, a subsidiary of Cadila Healthcare, acquired gastrointestinal brand 'Actibile' from drug firm Albert David.

R. Gregory Scheible, MD, is the first physician Indiana to implant Apollo Endosurgery's Orbera intragastric balloon in a patient using a non-surgical procedure.

Clinical Genomics recently closed a $15 million series A financing round.

GI Dynamics appointed Scott Schorer as president and CEO, effective immediately.

More articles on GI/endoscopy:
5 most read GI/endoscopy stories
What ulcerative colitis patients most want to know from their physicians
GI Dynamics names Scott Schorer CEO

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers